Surrozen director granted 5,550 stock options
Surrozen, Inc. director Mace Rothenberg received a grant of stock options as part of board compensation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Surrozen, Inc. director Mace Rothenberg received a grant of stock options as part of board compensation. The award covers 5,550 options to purchase Common Stock at an exercise price of $30.14 per share. The options vest and become exercisable on the anniversary of the May 13, 2026 grant date, conditioned on continuous service as a director, and expire on May 12, 2036. Following this grant, Rothenberg holds 5,550 options directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Director Stock Option (right to buy) | 5,550 | $0.00 | $0.00 |
Footnotes (1)
- F1. The options vest and become exercisable on the anniversary of the grant date, subject to continuous service as a director.
Key Figures
Key Terms
Director Stock Option financial
stock options financial
exercise price financial
vest financial
expiration date financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Surrozen (SRZN) director Mace Rothenberg report in this Form 4?
What is the exercise price of the Surrozen (SRZN) options granted to the director?
When do the Surrozen (SRZN) director stock options vest and become exercisable?
When do the Surrozen (SRZN) stock options granted to Mace Rothenberg expire?
How many Surrozen (SRZN) options does Mace Rothenberg hold after this transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.